141 results on '"Finkelstein MM"'
Search Results
2. Malignant mesothelioma among employees of a Connecticut factory that manufactured friction materials using chrysotile asbestos.
3. Asbestos fibre concentrations in the lungs of brake workers: another look.
4. The relationship between diabetes mellitus and traffic-related air pollution.
5. Ecologic proxies for household income: how well do they work for the analysis of health and health care utilization?
6. Relation between income, air pollution and mortality: a cohort study.
7. Safety works: getting past the very thought of change.
8. The relationship between parental occupation and bone cancer risk in offspring.
9. Depression severity and effect of antidepressant medications.
10. Holton et al., Characterization of asbestos exposures associated with the use of facial makeups. Risk Analysis, 42, 2129-2139.
11. Letter to the Editor: Re Fordyce et al. (2019) Vermont Talc Miners and Millers Cohort Study Update.
12. Malignant Mesothelioma Among Employees of a Connecticut Factory That Manufactured Friction Materials Using Chrysotile Asbestos: An Update.
13. Letter concerning: Burns AM, Barlow CA, Banducci AM, Unice KM, Sahmel J. Potential Airborne Asbestos Exposure and Risk Associated with the Historical Use of Cosmetic Talcum Powder Products.
14. Letter concerning: Occupational exposures to cosmetic talc and risk of mesothelioma: an updated pooled cohort and statistical power analysis with consideration of latency period by Gary M. Marsh et al. (Inhal Toxicol. 2019 Aug 5:1-11. doi:10.1080/08958378.2019.1645768).
15. Response to Marsh, G. M., Ierardi, A. M., Benson, S. M., & Finley, B. L. (2019). Occupational exposures to cosmetic talc and risk of mesothelioma: an updated pooled cohort and statistical power analysis with consideration of latency period. Inhalation toxicology, 31(6), 213-223.
16. Malignant Mesothelioma and Its Nonasbestos Causes.
17. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans.
18. Comments on "Dimensions of elongated mineral particles with implications for pathogenicity and classification as asbestiform versus cleavage fragments".
19. Response to: 'The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure' by Marinaccio et al .
20. Letter Concerning: Glynn ME, Keeton KA, Gaffney SH, Sahmel J. Ambient Asbestos Fiber Concentrations and Long-Term Trends in Pleural Mesothelioma Incidence Between Urban and Rural Areas in the United States (1973-2012). Risk Analysis 2018;38(3):454-471.
21. Reanalysis of non-occupational exposure to asbestos and the risk of pleural mesothelioma.
22. Re: Mortality of Talc Miners and Millers From Val Chisone, Northern Italy.
23. Re: Brent L. Finley, Stacey M. Benson & Gary M. Marsh (2017): Cosmetic talc as a risk factor for pleural mesothelioma: a weight of evidence evaluation of the epidemiology, Inhalation Toxicology, DOI: 10.1080/08958378.2017.1336187.
24. In reference to Asbestos exposure and laryngeal cancer mortality.
25. Historical ambient airborne asbestos concentrations in the United States.
26. Asbestos fibres in the lungs of an American mechanic who drilled, riveted, and ground brake linings: a case report and discussion.
27. Statins and musculoskeletal adverse events.
28. The analysis of asbestos count data with "nondetects": the example of asbestos fiber concentrations in the lungs of brake workers.
29. How physicians can survive the "perfect storm" developing in healthcare today--and thrive.
30. Letter to the Editor re Bernstein et al: Health risk of chrysotile revisited. Crit Rev Toxicol, 2013; 43(2): 154-183.
31. Pneumoconiosis and malignant mesothelioma in a family operated metal casting business that used industrial talc from New York state.
32. Letter concerning the paper by Finley and colleagues: dx.doi.org/10.1016/j.yrtph.2012.05.015.
33. Malignant mesothelioma incidence among talc miners and millers in New York State.
34. Be prepared in the post-PPACA liability and healthcare environment: assure, do not assume.
35. Use HCAHPS as a motivator to reenergize your five-star program, and make it personal.
36. A culture of safety: a business strategy for medical practices.
37. Mortality among subjects with chronic obstructive pulmonary disease or asthma at two respiratory disease clinics in Ontario.
38. Test tracking: patient safety as a quality-improvement and liability-reduction strategy.
39. Taking patient accountability to another level: because healthcare reform makes it necessary.
40. Absence of radiographic asbestosis and the risk of lung cancer among asbestos-cement workers: Extended follow-up of a cohort.
41. Healthcare reform: can you get ahead of the wave?
42. Lung cancer in the melt shops of Ontario steelmakers.
43. Five-star lessons learned: how to move up the curve in today's environment.
44. A cohort study of traffic-related air pollution and mortality in Toronto, Ontario, Canada.
45. Five-star service culture: enhancing satisfaction and reducing liability exposure.
46. Ethics training needs to emphasize disclosure and apology.
47. Adverse event management: your evidence to decrease professional liability risk.
48. Effectiveness of selective serotonin reuptake inhibitors.
49. Diesel particulate exposure and diabetes mortality among workers in the Ontario construction trades.
50. How a successful litigator decides whether or not to sue you.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.